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Abstract
Background: After the Food and Drug Administration Modernization Act of 1997, the registration of all clinical
trials became mandatory prior to publication. Our primary objective was to determine publication rates for
orthopaedic trauma trials registered with ClinicalTrials.gov. We further evaluated methodological consistency
between registration and publication.
Methods: We searched Clinical Trials.gov for all trials related to orthopaedic trauma. We excluded active trials and
trials not completed by July 2009, and performed a systematic search for publications resulting from registered
closed trials. Information regarding primary and secondary outcomes, intervention, study sponsors, and sample size
were extracted from registrations and publications.
Results: Of 130 closed trials, 37 eligible trials resulted in 16 publications (43.2%). We found no significant
differences in publication rates between funding sources for industry sponsored studies and nongovernment/
nonindustry sponsored studies (p > 0.05). About half the trials (45%) did not include the NCT ID in the publication.
Two (10%) publications had major changes to the primary outcome measure and ten (52.6%) to sample size.
Conclusions: Registration of orthopaedic trauma trials does not consistently result in publication. When trials are
registered, many do not cite NCT ID in the publication. Furthermore, changes that are not reflected in the registry
of the trial are frequently made to the final publication.
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Introduction
ClinicalTrials.gov (CTG) was developed by the U.S.
National Institutes of Health in collaboration with the
Food and Drug Administration (FDA) in February 2000
[1]. It was established after the FDA Modernization Act
of 1997, which made it a requirement for the Depart-
ment of Health and Human Services to establish a regis-
try of all clinical trials of experimental treatments for
serious or life-threatening diseases or conditions [2]. It
offers current information on clinical trials for a wide
range of diseases and conditions, allowing doctors,
researchers, and patients to locate clinical trials con-
ducted worldwide. CTG currently contains over 94,000
registered trials from 174 countries [3].
The database summarizes each registered trial and
gives information including but not limited to the pur-
pose of the study, recruiting status, criteria for patient
participation, and location of the trial and specific con-
tact information. Furthermore, additional information
such as research study design and condition under study
is outlined to help potential participants consider a par-
ticular trial.
Each listing on the registry is given a unique National
Clinical Trials Identifier (NCT ID) with the prefix ‘NCT’
and an 8-digit number that is used to locate and identify
a specific trial. We believe that the NCT ID should be
included in any final publication to allow the reader to
evaluate the strength of the trial by comparing it to the
original plans as outlined in the registry. We performed
a review of trials registered in CTG and relating to
orthopaedic trauma evaluating publication rates and
consistency of reporting. We hypothesized that the inci-
dence of registered trials not published would be high
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would be methodological differences between publica-
tion and registration methodology.
Methods
Eligibility criteria
Trials that were considered eligible to be included in
our analysis met the following criteria: 1) registered on
clinicaltrials.gov registry, 2) registered up to July 2009,
and 3) trials that were reported as closed. Ongoing trials
were excluded from analysis.
Search strategy
We performed a search of orthopaedic trauma trials
with the http://www.ClinicalTrials.gov database in
duplicate (MJ, HS) using the search terms (orthopaedic
trauma OR orthopedic trauma). We also performed a
search using the conditions listed on CTG including
“wounds and injuries” and “fracture, bone,”“ radius
fracture,”“ tibia fracture” and “sprains and strains.”
This resulted in 264 registered trials up to and includ-
ing July 2010. The search was further narrowed to
closed studies with the understanding that studies still
actively recruiting participants are unlikely to have
publications (n = 134). Refining the search resulted in
130 closed studies. Of these, we decided to review stu-
dies with an estimated completion date up to and
including July 2009 to allow adequate time for pre-
paration and submission of a manuscript and therefore
excluded those trials with a completion date after July
2009 (n = 67). Seven studies did not indicate a com-
pletion date or estimated completion date in the data-
base and were thus excluded. We also excluded non-
randomized and observational studies. Application of
this criteria resulted in 37 studies for subsequent ana-
lysis. Discrepancies in eligibility were resolved by con-
sensus. Agreement for final inclusion between
reviewers was excellent. (Kappa = 0.79; 95% confidence
interval, 0.46 to 0.94).
Because our results from our previous search terms
provided us with a larger number of trials to analyze,
we believe our search strategy is sufficient.
Publication rate
Each of the 130 closed studies were first assessed to
determine whether or not the investigators listed any
publications within the trial registry. If none were listed,
a search using key terms from the trial and the primary
investigator was performed using the Pubmed, EMBASE
and Ovid Medline databases. Suspected publications
were confirmed with the registry based on NCT ID,
publication date, authors, number of participants, pri-
mary and secondary outcome measures, and study
location.
Data abstraction
After identifying a published study, two of us (HS, MJ)
extracted data from both the CTG database and the publi-
cation including authors, year of publication, NCT ID and
its presence in the paper, trial status (complete, active, not
recruiting etc.), study start date, registration date and com-
pletion date, study sponsor, primary and secondary out-
come measures, study phase and design, study location,
inclusion and exclusion criteria, and sample size.
We evaluated the agreement between the methodol-
ogy reported in the registry and that of the publication.
Major discrepancies were defined using a modification
of criteria previously reported by Chan et al. [4]: (1) a
pre-specified primary outcome was reported as second-
ary or was not labeled as either primary or secondary in
the publication; (2) a pre-specified primary outcome was
omitted from the published article; (3) a new primary
outcome was introduced in the published article.
Statistical analysis
Study characteristics were presented with descriptive statis-
tics. Association between trial sponsor and incidence of
publication was anlayzed with the Fisher exact test. All p
values were two tailed with a level of significance set at 0.05.
Kappa statistics were used to calculate the agreement
between reviewers on study eligibility.
Results
Characteristics of registered trials
The 37 eligible orthopaedic trauma trials included in
CTG spanned North and South America, Europe, Asia
and Africa. Most trials evaluated surgical interventions,
however there were also drug and therapeutic interven-
tions such as the use radiation. Further details of the eli-
gible trials can be found in Table 1.
Table 1 Details of Eligible Trials
Orthopaedic Trauma
Number of Trials 36
Number of Publications (%) 20 (54%)
Intervention
Surgical 20
Drug 14
Other 3
Median Estimated Sample Size 298
(Range) (22-3432)
Sponsor
Industry 14
Government 4
Nonindustry/nongovernment 19
Characteristics of the 37 closed trials identified in CTG that were completed
up to and including July 2009.
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In total, 16 of 37 (43.2%) registered trials with an esti-
mated completion date up to and including July 2009
were confirmed to have publications. Four interim pub-
lications [5-8] defined as ongoing trials with publications
prior to the study completion were also identified for a
total of 20 publications included in our analysis of con-
sistency with trial registration. Of the 4 interim publica-
tions, 1 was sponsored by industry [7], and the
remaining 3 by a nongovernment/nonindustry source
[5,6,8]. Nongovernment/nonindustry sponsored trials
had the highest publication rate, with 9 of 19 (47.3%)
trials resulted in publication [9-17]. In comparison, 6 of
14 (42.9%) industry sponsored trials resulted in publica-
tion [18-23], and 1 of 4 (25%) government sponsored
trials [24] were published. There were no significant dif-
ferences in publication rates for industry sponsored stu-
dies and nongovernment/nonindustry sponsored studies
(p = 0.92), between government sponsored and nongo-
vernment/nonindustry sponsored trials (p =0 . 6 )o r
industry sponsored trials (p = 0.62).
Fifteen of the 20 publications were from a trial with a
status of “completed” in CTG [9-19,21-24]. The remain-
ing publications were listed as active but not recruiting
[5-8], and terminated in the database [20]. One addi-
tional study had a published abstract but no complete
manuscript [25]. We verified this by confirming that the
title, author, outcome measures, and study dates were
the same as those mentioned in the registered trial. Of
the 20 publications, the NCT ID was included in 11
(55%) [8,9,11,12,14,15,17,18,20,23,24].
Characteristics of published trials can be found in
Table 2.
Consistency between trial registration and publication
We compared the study sample size proposed on CTG
with the actual study enrolment reported in the publica-
tion. There was one study that did not include a pro-
posed sample size in the registry [10]. In 9 of the
remaining 19 studies (47.3%), enrolment as stated in
CTG exactly matched that of the final publication
[5,7-9,12,16-18,24]. Of the 10 publications (52.6%) with
an inconsistent sample size, 7 had a smaller sample than
the one reported in CTG [6,11,13,15,19,20,22], and 3
had a larger sample [14,21,23]. The sample size discre-
pancy in all publications differed from the original figure
by a minimum of ± 6%.
We compared the agreement between the primary and
secondary outcome measures as stated in the publica-
tion and on CTG. The registry listed a primary outcome
measure for all trials and secondary outcome measures
for 18 trials. One trial did not list a secondary outcome
measure in the registry or publication [24]. Two of the
20 publications (10%) had a major discrepancy with the
registry. Each of these publications did not state the pri-
mary outcome measure despite identifying one in the
registry [6,18]. All but two of the remaining 18 publica-
tions were consistent with the registry with regards to
primary and secondary outcomes [5,7-12,15-17,19-23].
Two publications did not report a secondary outcome
measure in the manuscript that had been listed in the
registry [13,14].
Discussion
As a result of our search of orthopaedic trauma trials
registered in CTG, we found that only 16 of 37 (43.2%)
trials resulted in publication as of March 2011. Further-
more, final results of completed trials were not reported
in the registry, and many publications were inconsistent
in sample size and reporting of outcomes with the origi-
nal report in CTG. We are unable to determine the rea-
son for trials failing to result in publication. Several
possibilities exist, including that the data was never ana-
lyzed, the journals elected not to publish, the authors
elected not to publish the findings because they failed to
substantiate the study hypothesis or believed the results
contradicted the hypothesis. Another possibility may be
that papers were not accepted for publication because of
non-significant results. Regardless, the results of this
study represent a large potential for publication bias in
the orthopaedic trauma literature.
Table 2 Characteristics of Published Orthopaedic Trauma
Trials
No. (%) of Articles
Industry Government Neither
(n = 14) (n = 4) (n = 19)
Number of Registered Trials 14/37 4/37 19/37
Trials Published 6 1 9
Interim Publications 1 0 3
NCT ID Reported in Publication (%) 3 (42.8) 1 (100) 7 (58.3)
Major Outcome Measure
Discrepancies
1 (14.2) 0 3 (25)
Primary Outcome Not Labelled in 1 0 1
Publication
Secondary Outcome Not
Labelled in
002
Publication
Discrepancies Favouring Statistically 0 0 0
Significant Results
Major Sample Size Changes (%)* 3 (42.8) 0 6 (50)
Trial Type
Interventional RCT 6 (100) 1 (100) 9 (100)
Characteristics of trials conducted in North America, Europe and New Zealand
registered on CTG, classified by funding source
*defined as ± 6% of the sample size listed on CTG
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comes have been more likely to be submitted for publi-
cation and accepted by journals. Dickersinet al. [26]
found that trials with statistically significant results were
2.9 times more likely to be published. Several authors
have recently reported similar problems in the orthopae-
dic literature [27,28]. Publication bias may lead to
wasted resources due to unnecessary duplicate studies,
as well as potential harm to study participants [29].
Nongovernment/nonindustry sponsored studies
demonstrated the highest rate of publication (47.3%),
while industry sponsored trials were similar (42.9%).
Only one of four (25%) completed government spon-
sored trials were published. This is contrary to the
results of several studies that have found that in general,
industry sponsored studies have the lowest rates of pub-
lication [30].
Almost half (45%) of trials did not include the NCT
ID in their publication. Including the NCT ID in the
publication should be made mandatory as it allows the
reader to locate and identify the trial on CTG and com-
pare the original study design with the published design.
Published manuscripts where the power or primary out-
come measures have been changed can alert the reader
to concerns of study validity.
We also found that 2 (10%) publications had major
changes to the primary outcome measure and 10
(52.6%) to sample size. Discrepancies between trial reg-
istry and publication have been observed in previous
studies and are a concern as they may compromise the
integrity of the conclusions that can be drawn from the
study [31]. Simply adding patients to a study may take a
clinically insignificant finding, and make it statistically
significant for the reader. Mandatory registration would
allow journal editors to examine trial information when
reviewing the manuscript to uncover such discrepancies.
We reviewed requirements for authors in various
orthopaedic surgery journals to verify whether the jour-
nals support trial registration prior to a publication. We
found that the Journal of Arthroplasty, British Journal of
Bone and Joint Surgery, Journal of Orthopaedic Surgery,
and the Journal of Orthopaedic Trauma did not include
information about requirements related to the registra-
tion of clinical trials. Acta Orthopaedica Scandinavica
instructs authors to comply with the CONSORT guide-
lines for reporting of clinical trials [32]. Although these
guidelines ensure that the author submits the registra-
tion number and the name of the registry in the publi-
cation, they do not require the author to register a
clinical trial in a registry. Clinics in Orthopaedic Sur-
gery, the American Journal of Bone and Joint Surgery,
and BioMed Central explicitly stated that registration of
all clinical trials was required. Improving instructions
for authors submitting manuscripts to journals, and
making trial registration a necessity is an essential step
to move towards reliable reporting of clinical trial
results [33,34].
The limitations of our study include the uncertainty of
the time it may take between submission of a paper to a
journal and approval for publication. A potential weak-
ness is that although we reviewed studies until March
2011 (publication time between July 2009-March 2011),
it is possible that there are completed trials in print that
are currently awaiting publication. Some journals may
publish studies at a faster pace than others. It may be
that there were studies that were published without our
knowledge, completed early, or submitted before their
completion date. Furthermore, it may be that changes to
trial information on CTG simply may not be updated
frequently enough and may cause the available informa-
tion to be misleading. Also, it is possible that studies
that did not focus on orthpaedic trauma but included
some aspect of it were overlooked because they did not
correspond with the search terms on CTG.
Our study also has several strengths. We conducted
an extensive search in duplicate for publications of
closed studies using several different search methods.
We also conducted exhaustive searches for interim pub-
lications, and publications resulting from studies listed
as terminated or withdrawn.
Conclusions
The results of our review of orthopedic trauma trials on
ClinicalTrials.gov indicate that registration does not
consistently result in publication or disclosure of results.
Although only 10% of the publications had major discre-
pancy between trial registry and publication, smaller
changes are frequently made to the final presentation of
the data that are not reflected in the registry of the trial.
When trials are registered, a great number of them do
not cite the registration number in the publication, mak-
i n gi ti m p o s s i b l ef o rt h er e a d e rt oe v a l u a t et h es t u d y
conclusions in relation to the original plans for the trial.
We suggest all journals should make registration of clin-
ical trials mandatory for publication.
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